What You Should Know:
- The average price per insulin unit dropped 42%, from $0.33 in 2019 to $0.19, in mid-2024, according to a new report from GoodRx. The drop represent the lowest average recorded in a decade.
- Thanks to the Inflation Reduction Act and voluntary price cuts by major insulin manufacturers, prices have seen significant declines. Products like Lantus, Novolin N, Humalog, and Humulin N are now more affordable than they have been in years.
Insulin Costs
Read More
Most Popular
The Quintuple Aim: Redefining Patient-Centered Care in the Digital Age
Patient-centered care is constantly evolving, driven by fresh insights, innovative resources, and advancements in technology and healthcare delivery.
The Quintuple Aim is a healthcare framework at the heart of patient-centered care. It broadens the focus of healthcare improvement by prioritizing health equity alongside enhancing patient experiences, improving outcomes, reducing costs, and supporting clinician well-being. The Quintuple Aim emphasizes trust, open communication, and
Read More
How Clinical Pharmacist-Led Telehealth Models Are Transforming Diabetes Care
Diabetes, a chronic condition affecting millions of Americans, is on the rise. According to the CDC, 15.8% of the U.S. population now lives with diabetes. With over 38 million people managing this complex disease, effective care is essential. Yet, access to diabetes care has become increasingly challenging, especially for underserved communities. The closure of primary care clinics by major retail pharmacy chains has further strained access to care, leaving vulnerable populations without the
Read More
25 Executive Digital Health Predictions & Trends to Watch in 2025
From the rise of personalized nutrition to the growing importance of interoperability, healthcare is on the cusp of transformative change. Explore the key trends and predictions that will shape the healthcare landscape in 2025, according to 25 industry leaders.
Naveen Jain, CEO and Founder of Viome
"By 2025, personalized nutrition will evolve from a niche innovation to a cornerstone of mainstream wellness. Faced with escalating healthcare costs, insurers and employers will adopt
Read More
HHS Unveils AI Strategic Plan for Healthcare, Human Services and Public Health
What You Should Know:
- The U.S. Department of Health and Human Services (HHS) today has released its Artificial Intelligence (AI) Strategic Plan, outlining a comprehensive vision for how AI can transform healthcare, human services, and public health.
- The HHS AI Strategic Plan serves as a call to action for the healthcare industry, encouraging stakeholders to embrace AI's potential while prioritizing ethical considerations and equitable access.
HHS AI Strategic Plan
Read More
Amwell Divests Psychiatric Care Business to Avel eCare for $21M
What You Should Know:
- Amwell (NYSE: AMWL), a leading global provider of digital care solutions, announced today the sale of its Amwell Psychiatric Care (APC) business to Avel eCare, a prominent provider of clinician-to-clinician telehealth services.
- The strategic divestiture allows Amwell to further sharpen its focus on key growth areas, drive greater efficiencies, and better align with evolving client needs in the digital health market.
Strategic Divestiture and
Read More
What’s Next for Women’s Health in 2025? 5 Trends That Are Driving The Sector
Women’s health is finally getting the treatment it deserves. Historically overlooked, downplayed, and neglected, investors have spotted the largely untapped opportunity the sector presents. Venture capital investment in the women’s health sector has surged by 314% over the past five years, and despite the recent slowdown in startup funding, mid-year data shows the sector is on track for another record-breaking year.
While women spend 25% more time in poor health compared to men, the prognosis
Read More
Transcarent to Acquire Accolade in $621M Deal, Creating a Unified Platform for Personalized Healthcare
What You Should Know:
- Transcarent, a health and care platform, announced today that it will acquire Accolade (NASDAQ: ACCD), a leader in health advocacy and primary care, for $7.03 per share in cash, representing a total equity value of approximately $621M. The merger consideration represents a significant premium over Accolade's recent stock price, reflecting the strategic value of this transaction. Transcarent will finance the acquisition through equity financing led by
Read More
Providence Ventures Spins Out, Forms Allumia Ventures
What You Should Know:
- Allumia Ventures, formerly known as Providence Ventures, announced its spin-off from Providence to become an independent venture capital firm.
- The spin out follows the first close of its third fund, marking a significant milestone in the firm's evolution. The firm will continue to work closely with Providence as an Anchor Limited Partner while inviting a select group of other healthcare organizations to join its third fund.
Allumia Ventures
Read More
The RCM Arms Race: How AI is Reshaping Healthcare Finance in 2025
As healthcare providers head into 2025, a technological arms race is reshaping revenue cycle management (RCM), with artificial intelligence (AI) emerging as the decisive factor between financial success and struggle. With approximately 46% of hospitals and health systems already utilizing AI in their RCM operations, the industry stands at a critical juncture where matching payer sophistication has become imperative for survival. This transformation represents a fundamental shift in how
Read More
